share_log

8-K: Consulting Agreement

8-K: Consulting Agreement

8-K:諮詢協議
美股SEC公告 ·  09/17 16:25
Moomoo AI 已提取核心訊息
On September 13, 2024, Cassava Sciences, Inc., a biopharmaceutical company, announced the signing of a non-exclusive Consulting Agreement with its former CEO, Remi Barbier. Under the agreement, Barbier will provide consulting services to Cassava for one year, with the option for the company to extend for an additional year. The services will include support for scientific research and assistance in obtaining governmental approvals for the company's products. Barbier will be compensated at a rate of $100 per hour and has agreed to confidentiality and other customary terms. The agreement can be terminated by either party with thirty days' notice and does not affect Barbier's severance benefits as previously reported in a Form 8-K filed on July 17, 2024. The full Consulting Agreement was attached as Exhibit 10.1 to the report.
On September 13, 2024, Cassava Sciences, Inc., a biopharmaceutical company, announced the signing of a non-exclusive Consulting Agreement with its former CEO, Remi Barbier. Under the agreement, Barbier will provide consulting services to Cassava for one year, with the option for the company to extend for an additional year. The services will include support for scientific research and assistance in obtaining governmental approvals for the company's products. Barbier will be compensated at a rate of $100 per hour and has agreed to confidentiality and other customary terms. The agreement can be terminated by either party with thirty days' notice and does not affect Barbier's severance benefits as previously reported in a Form 8-K filed on July 17, 2024. The full Consulting Agreement was attached as Exhibit 10.1 to the report.
2024年9月13日,Cassava Sciences公司,一家生物製藥公司,宣佈與其前CEO Remi Barbier簽訂了一份非排他性的諮詢協議。根據協議,Barbier將爲Cassava提供一年的諮詢服務,公司有選擇權可以延長一年。這些服務將包括對科學研究的支持,以及協助公司獲得政府批准其產品的幫助。Barbier將按每小時100美元的費率獲得報酬,並同意保密和其他經常條款。協議可以由任一方在提前通知三十天的情況下終止,並不會影響Barbier之前在2024年7月17日提交的8-k表格中所報告的遣散福利。完整的諮詢協議作爲附件10.1萬億連接在報告中。
2024年9月13日,Cassava Sciences公司,一家生物製藥公司,宣佈與其前CEO Remi Barbier簽訂了一份非排他性的諮詢協議。根據協議,Barbier將爲Cassava提供一年的諮詢服務,公司有選擇權可以延長一年。這些服務將包括對科學研究的支持,以及協助公司獲得政府批准其產品的幫助。Barbier將按每小時100美元的費率獲得報酬,並同意保密和其他經常條款。協議可以由任一方在提前通知三十天的情況下終止,並不會影響Barbier之前在2024年7月17日提交的8-k表格中所報告的遣散福利。完整的諮詢協議作爲附件10.1萬億連接在報告中。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息